The Multifaceted Role of Protein Kinase CK2 in High-risk Acute Lymphoblastic Leukemia

Overview

Journal Haematologica

Specialty Hematology

Date 2020 Aug 21

PMID 32817283

Citations 3

Authors

Yun Zhou

Haiwei Lian

Ning Shen

Sovannarith Korm

Andrew Kwok Ping Lam

Olivia Layton

Leah N Huiting

Dun Li

Kelly Miao

Aozhuo Zeng

Esther Landesman-Bollag

David C Seldin

Hui Fu

Li Hong

Hui Feng

Affiliations

Soon will be listed here.

Citing Articles

CK2β-regulated signaling controls B cell differentiation and function.

Quotti Tubi L, Mandato E, Canovas Nunes S, Arjomand A, Zaffino F, Manni S Front Immunol. 2023; 13:959138.

PMID: 36713383 PMC: 9874936. DOI: 10.3389/fimmu.2022.959138.

In silico investigations identified Butyl Xanalterate to competently target CK2α (CSNK2A1) for therapy of chronic lymphocytic leukemia.

Alsagaby S, Iqbal D, Ahmad I, Patel H, Ahmad Mir S, Madkhali Y Sci Rep. 2022; 12(1):17648.

PMID: 36271116 PMC: 9587039. DOI: 10.1038/s41598-022-21546-0.

Green Synthesis and Anticancer Potential of 1,4-Dihydropyridines-Based Triazole Derivatives: In Silico and In Vitro Study.

Bijani S, Iqbal D, Mirza S, Jain V, Jahan S, Alsaweed M Life (Basel). 2022; 12(4).

PMID: 35455010 PMC: 9029820. DOI: 10.3390/life12040519.

References

Borgo C, Ruzzene M . Role of protein kinase CK2 in antitumor drug resistance. J Exp Clin Cancer Res. 2019; 38(1):287. PMC: 6612148. DOI: 10.1186/s13046-019-1292-y. View

Chua M, Ortega C, Sheikh A, Lee M, Abdul-Rassoul H, Hartshorn K . CK2 in Cancer: Cellular and Biochemical Mechanisms and Potential Therapeutic Target. Pharmaceuticals (Basel). 2017; 10(1). PMC: 5374422. DOI: 10.3390/ph10010018. View

Seldin D, Leder P . Casein kinase II alpha transgene-induced murine lymphoma: relation to theileriosis in cattle. Science. 1995; 267(5199):894-7. DOI: 10.1126/science.7846532. View

Piazza F, Manni S, Ruzzene M, Pinna L, Gurrieri C, Semenzato G . Protein kinase CK2 in hematologic malignancies: reliance on a pivotal cell survival regulator by oncogenic signaling pathways. Leukemia. 2012; 26(6):1174-9. DOI: 10.1038/leu.2011.385. View

Ko R, Ji L, Barnette P, Bostrom B, Hutchinson R, Raetz E . Outcome of patients treated for relapsed or refractory acute lymphoblastic leukemia: a Therapeutic Advances in Childhood Leukemia Consortium study. J Clin Oncol. 2009; 28(4):648-54. PMC: 2815999. DOI: 10.1200/JCO.2009.22.2950. View

Borga C, Park G, Foster C, Burroughs-Garcia J, Marchesin M, Shah R . Simultaneous B and T cell acute lymphoblastic leukemias in zebrafish driven by transgenic MYC: implications for oncogenesis and lymphopoiesis. Leukemia. 2018; 33(2):333-347. PMC: 6365377. DOI: 10.1038/s41375-018-0226-6. View

Gutierrez A, Grebliunaite R, Feng H, Kozakewich E, Zhu S, Guo F . Pten mediates Myc oncogene dependence in a conditional zebrafish model of T cell acute lymphoblastic leukemia. J Exp Med. 2011; 208(8):1595-603. PMC: 3149218. DOI: 10.1084/jem.20101691. View

Feng H, Langenau D, Madge J, Quinkertz A, Gutierrez A, Neuberg D . Heat-shock induction of T-cell lymphoma/leukaemia in conditional Cre/lox-regulated transgenic zebrafish. Br J Haematol. 2007; 138(2):169-75. DOI: 10.1111/j.1365-2141.2007.06625.x. View

Gowda C, Sachdev M, Muthusami S, Kapadia M, Petrovic-Dovat L, Hartman M . Casein Kinase II (CK2) as a Therapeutic Target for Hematological Malignancies. Curr Pharm Des. 2016; 23(1):95-107. DOI: 10.2174/1381612822666161006154311. View

10.

Borga C, Foster C, Iyer S, Garcia S, Langenau D, Frazer J . Molecularly distinct models of zebrafish Myc-induced B cell leukemia. Leukemia. 2018; 33(2):559-562. PMC: 6365381. DOI: 10.1038/s41375-018-0328-1. View

11.

Garcia E, Iyer S, Garcia S, Loontiens S, Sadreyev R, Speleman F . Cell of origin dictates aggression and stem cell number in acute lymphoblastic leukemia. Leukemia. 2018; 32(8):1860-1865. PMC: 6620784. DOI: 10.1038/s41375-018-0130-0. View

12.

Penner C, Wang Z, Litchfield D . Expression and localization of epitope-tagged protein kinase CK2. J Cell Biochem. 1997; 64(4):525-37. View